Human Papillomavirus Type 16 and TP53 Mutation in Oral Cancer

TP53 mutations were analyzed in 35 human papillomavirus (HPV) type 16 DNA-positive cancers of the oral cavity and oropharynx and in 35 HPV DNA-negative cancers matched by subsite, country, sex, age, and tobacco and alcohol consumption. Wild-type TP53 was found more frequently in cancer specimens that contained HPV16 DNA than in those that did not. All 14 HPV16 DNA-positive cancers in HPV16 E6 antibody-positive patients contained wild-type TP53, compared with 50% of corresponding HPV DNA-negative cancers (matched odds ratio, ∞; 95% confidence interval, 1.4–∞). In contrast, for HPV16 DNA-positive cancers in E6-negative patients, wild-type TP53 frequency was similar to that in corresponding HPV DNA-negative cancers (matched odds ratio, 1.0; 95% confidence interval, 0.2–5.4). TP53 inactivation is a major mechanism of HPV-related carcinogenesis in the oral cavity and oropharynx. The role of HPV in cancers also containing TP53 mutations remains to be clarified.

[1]  S. Franceschi,et al.  Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. , 2003, Journal of the National Cancer Institute.

[2]  M. Lerman,et al.  Epigenetic inactivation of RASSF1A in head and neck cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  D. Galloway.  Papillomavirus vaccines in clinical trials. , 2003, The Lancet. Infectious diseases.

[4]  M. Plummer,et al.  Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis , 2003, British Journal of Cancer.

[5]  N. Tretyakova,et al.  Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers , 2002, Oncogene.

[6]  K. Kelsey,et al.  Human papillomavirus type 16 and squamous cell carcinoma of the head and neck. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[7]  C. Harris,et al.  The IARC TP53 database: New online mutation analysis and recommendations to users , 2002, Human mutation.

[8]  S. Franceschi,et al.  Oral cancer in southern India: The influence of smoking, drinking, paan‐chewing and oral hygiene , 2002, International journal of cancer.

[9]  F. Bosch,et al.  Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control , 2002, Oncogene.

[10]  G. Snow,et al.  Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas , 2001, International journal of cancer.

[11]  M. Pawlita,et al.  A generic capture ELISA for recombinant proteins fused to glutathione S-transferase: validation for HPV serology. , 2001, Journal of immunological methods.

[12]  K. Shah,et al.  Human papillomavirus–associated head and neck squamous cell carcinoma: mounting evidence for an etiologic role for human papillomavirus in a subset of head and neck cancers , 2001, Current opinion in oncology.

[13]  P. Simpson,et al.  Statistical methods in cancer research , 2001, Journal of surgical oncology.

[14]  D. Sidransky,et al.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. , 2000, Journal of the National Cancer Institute.

[15]  C. la Vecchia,et al.  Comparison of the effect of smoking and alcohol drinking between oral and pharyngeal cancer , 1999, International journal of cancer.

[16]  S. Schwartz,et al.  Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. , 1998, Journal of the National Cancer Institute.

[17]  M. Pawlita,et al.  Antibodies against Early Proteins of Human Papillomaviruses as Diagnostic Markers for Invasive Cervical Cancer , 1998, Journal of Clinical Microbiology.

[18]  C. Meijer,et al.  Role of human papillomaviruses in cancer of the respiratory and upper digestive tract. , 1997, Clinics in dermatology.

[19]  S. Franceschi,et al.  Human papillomavirus and cancers of the upper aerodigestive tract: a review of epidemiological and experimental evidence. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[20]  L. Crawford,et al.  Human Papillomavirus E6 and E7: Proteins which deregulate the cell cycle , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[21]  C. Meijer,et al.  Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus. , 1994, The Journal of general virology.

[22]  N. Breslow,et al.  Statistical methods in cancer research. Vol. 1. The analysis of case-control studies. , 1981 .

[23]  J. McDougall.  Immortalization and transformation of human cells by human papillomavirus. , 1994, Current topics in microbiology and immunology.

[24]  N. Breslow,et al.  The analysis of case-control studies , 1980 .